You are here

Large-scale study of NSAIDS finds no link to heart attack

Celebrex is less likely than naproxen and ibuprofen to cause kidney and gastrointestinal problems


IN 2004, when drugmaker Merck voluntarily pulled the pain-reliever Vioxx off the market amid evidence that it increased the risk of heart attacks, concern naturally turned to its nearly identical rival, Celebrex.

The medication works the same way, by inhibiting...

Market voices on: